Blue Trust Inc. Grows Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

Blue Trust Inc. lifted its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 124.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,828 shares of the company’s stock after buying an additional 2,122 shares during the period. Blue Trust Inc.’s holdings in LifeStance Health Group were worth $27,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in LFST. Geode Capital Management LLC grew its holdings in shares of LifeStance Health Group by 26.8% in the third quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company’s stock worth $24,170,000 after purchasing an additional 729,794 shares during the last quarter. Wellington Management Group LLP lifted its holdings in LifeStance Health Group by 15.2% in the third quarter. Wellington Management Group LLP now owns 4,830,441 shares of the company’s stock worth $33,813,000 after buying an additional 638,385 shares during the period. Parkman Healthcare Partners LLC bought a new stake in shares of LifeStance Health Group during the third quarter valued at approximately $3,150,000. Charles Schwab Investment Management Inc. boosted its position in shares of LifeStance Health Group by 36.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company’s stock worth $7,731,000 after purchasing an additional 297,723 shares in the last quarter. Finally, Principal Financial Group Inc. grew its stake in shares of LifeStance Health Group by 6.1% in the third quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company’s stock worth $28,817,000 after acquiring an additional 235,316 shares during the last quarter. 85.50% of the stock is owned by hedge funds and other institutional investors.

LifeStance Health Group Stock Performance

NASDAQ LFST opened at $8.06 on Tuesday. The business has a 50-day moving average price of $7.65 and a 200-day moving average price of $7.03. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a twelve month low of $4.64 and a twelve month high of $9.20. The firm has a market cap of $3.08 billion, a price-to-earnings ratio of -31.00 and a beta of 1.28.

Insider Buying and Selling at LifeStance Health Group

In related news, Director Robert Bessler sold 75,000 shares of the firm’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $7.54, for a total value of $565,500.00. Following the completion of the transaction, the director now directly owns 1,424,447 shares of the company’s stock, valued at approximately $10,740,330.38. This trade represents a 5.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 6.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on LFST shares. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price objective for the company in a report on Monday, December 16th. Barclays increased their price target on shares of LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research report on Monday, November 11th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $8.70.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.